BackAzurRx BioPharma Overview

AzurRx BioPharma Other Current Liabilities

Latest other current liabilities for AZRX: $9.7M.

Get informed when a big investor buys or sells

+ Follow
Other Current Liabilities
$9.67M
↓ 61.40% YoYΔ $-15.38M vs prior year quarter

Peer average

Loading

AzurRx BioPharma Other Current Liabilities History

Loading

AzurRx BioPharma vs. peers: Other Current Liabilities Comparison

Loading

AzurRx BioPharma Other Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

AzurRx BioPharma (AZRX) FAQ

As of the most recent data (March 2026), AZRX shows a other current liabilities of $9.7M. That compares with $25M in the prior-year period — down 61.4% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, AZRX's other current liabilities is now $9.7M (was $25M) — a 61.4% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether AzurRx BioPharma is outperforming or lagging.

Tracking AZRX's other current liabilities over time shows whether AzurRx BioPharma is scaling, shrinking, or reshaping that part of the business. The current reading is $9.7M That compares with $25M in the prior-year period — down 61.4% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this other current liabilities page, Stockcircle has AzurRx BioPharma's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect other current liabilities (currently $9.7M) with ownership activity and broader fundamentals.

AzurRx BioPharma's other current liabilities is $9.7M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.